In conclusion, chemerin serum levels were demonstrated to be elevated in PCOS patients compared to the non-PCOS group, with this increase being most pronounced in obese PCOS patients, but significantly lower or absent in non-obese women. The gene discussed is RARRES2; the disease is polycystic ovary syndrome.